Katie Fayer
Sr Analyst, Talent Acquisition Operations @Alnylam Pharmaceuticals
Signup · Get unlimited contacts
WORK HISTORY
Sr Analyst, Talent Acquisition Operations @Alnylam Pharmaceuticals
Cambridge, MA, US
Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by “interfering” with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality.
EDUCATION
Castleton University
B.S., Communication; Public Relations
Stony Brook University
Paralegal Certificate, Legal Studies, General
SKILLS
ABOUT KATIE FAYER
Talent Acquisition Operations @ Alnylam
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.